Functional and structural remodeling of the myocardial microvasculature in early experimental hypertension

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 290, Issue 3, 2006, Pages

  Rodriguez Porcel, Martin ^a   Zhu, Xiang Yang ^a   Chade, Alejandro R ^a   Amores Arriaga, Beatriz ^a   Caplice, Noel M ^a   Ritman, Erik L ^a,b   Lerman, Amir ^a   Lerman, Lilach O ^a,b,c  

^a Mayo Clinic   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

^c MAYO CLINIC   (United States)

Author keywords

Growth factors; Imaging; Microcirculation; Microcomputed tomography

Indexed keywords

ADENOSINE; GROWTH FACTOR; GROWTH PROMOTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VOLUME; CONTROLLED STUDY; ELECTRON BEAM TOMOGRAPHY; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HYPERTENSION; MICROCIRCULATION; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; RENOVASCULAR HYPERTENSION; SWINE; ANIMAL; CONVALESCENCE; DISEASE MODEL; FEMALE; HEART VENTRICLE REMODELING; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; GROWTH SUBSTANCES; HYPERTENSION; MICROCIRCULATION; NEOVASCULARIZATION, PATHOLOGIC; RECOVERY OF FUNCTION; SWINE; VENTRICULAR REMODELING;

EID: 33645734648     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00538.2005     Document Type: Article

References (48)

1. Aronow WS, Epstein S, and Koenigsberg M. Usefulness of echocardiographic left ventricular hypertrophy and silent ischemia in predicting new cardiac events in elderly patients with systemic hypertension or coronary artery disease. Angiology 41: 189-193, 1990.
2. Bentley MD, Rodriguez-Porcel M, Lerman A, Sarafov MH, Romero JC, Pelaez LI, Grande JP, Ritman EL, and Lerman LO. Enhanced renal cortical vascularization in experimental hypercholesterolemia. Kidney Int 61: 1056-1063, 2002.
3. Chade AR, Bentley MD, Zhu X, Rodriguez-Porcel M, Niemeyer S, Amores-Arriaga B, Napoli C, Ritman EL, Lerman A, and Lerman LO. Antioxidant intervention prevents renal neovascularization in hypercholesterolemic pigs. J Am Soc Nephrol 15: 1816-1825, 2004.
4. Chade AR, Rodriguez-Porcel M, Grande JP, Krier JD, Lerman A, Romero JC, Napoli C, and Lerman LO. Distinct renal injury in early atherosclerosis and renovascular disease. Circulation 106: 1165-1171, 2002.
5. 1-receptor blockade in human hypertension. Am J Hypertens 11: 548-553, 1998.
6. Damon DH, Lange DL, and Hattler BG. In vitro and in vivo vascular actions of basic fibroblast growth factor (bFGF) in normotensive and spontaneously hypertensive rats. J Cardiovasc Pharmacol 30: 278-284, 1997.
7. Dvorak HF, Brown LF, Detmar M, and Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146: 1029-1039, 1995.
8. Gerwins P, Skoldenberg E, and Claesson-Welsh L. Function of fibroblast growth factors and vascular endothelial growth factors and their receptors in angiogenesis. Crit Rev Oncol Hematol 34: 185-194, 2000.
9. Gu JW, Fortepiani LA, Reckelhoff JF, Adair TH, Wang J, and Hall JE. Increased expression of vascular endothelial growth factor and capillary density in hearts of spontaneously hypertensive rats. Microcirculation 11: 689-697, 2004.
10. Harrison DG, Florentine MS, Brooks LA, Cooper SM, and Marcus ML. The effect of hypertension and left ventricular hypertrophy on the lower range of coronary autoregulation. Circulation 77: 1108-1115, 1988.
11. Hasdai D, Gibbons RJ, Holmes DR Jr, Higano ST, and Lerman A. Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects. Circulation 96: 3390-3395, 1997.
12. Jorgensen SM, Demirkaya O, and Ritman EL. Three-dimensional imaging of vasculature and parenchyma in intact rodent organs with X-ray micro-CT. Am J Physiol Heart Circ Physiol 275: H1103-H1114, 1998.
13. Kannel WB. Historic perspectives on the relative contributions of diastolic and systolic blood pressure elevation to cardiovascular risk profile. Am Heart J 138: 205-210, 1999.
14. Kersten JR, Pagel PS, Chilian WM, and Warltier DC. Multifactorial basis for coronary collateralization: a complex adaptive response to ischemia. Cardiovasc Res 43: 44-57, 1999.
15. Kosmidou I, Xagorari A, Roussos C, and Papapetropoulos A. Reactive oxygen species stimulate VEGF production from C2C12 skeletal myotubes through a PI3K/Akt pathway. Am J Physiol Lung Cell Mol Physiol 280: L585-L592, 2001.
16. Kurz C, Hefler L, Zeisler H, Schatten C, Husslein P, and Tempfer C. Maternal basic fibroblast growth factor serum levels are associated with pregnancy-induced hypertension. J Soc Gynecol Investig 8: 24-26, 2001.
17. Kuwabara K, Ogawa S, Matsumoto M, Koga S, Clauss M, Pinsky DJ, Lyn P, Leavy J, Witte L, Joseph-Silverstein J, Furie MB, Torcia G, Cozzolino F, Kamada T, and Stern DM. Hypoxia-mediated induction of acidic/basic fibroblast growth factor and platelet-derived growth factor in mononuclear phagocytes stimulates growth of hypoxic endothelial cells. Proc Natl Acad Sci USA 92: 4606-4610, 1995.
18. Kuwahara F, Kai H, Tokuda K, Shibata R, Kusaba K, Tahara N, Niiyama H, Nagata T, and Imaizumi T. Hypoxia-inducible factor-1alpha/vascular endothelial growth factor pathway for adventitial vasa vasorum formation in hypertensive rat aorta. Hypertension 39: 46-50, 2002.
19. Laine H, Raitakari OT, Niinikoski H, Pitkanen OP, Iida H, Viikari J, Nuutila P, and Knuuti J. Early impairment of coronary flow reserve in young men with borderline hypertension. J Am Coll Cardiol 32: 147-153, 1998.
20. Le DE, Bin JP, Coggins MP, Wei K, Lindner JR, and Kaul S. Relation between myocardial oxygen consumption and myocardial blood volume: a study using myocardial contrast echocardiography. J Am Soc Echocardiogr 15: 857-863, 2002.
21. Lerman LO, Schwartz RS, Grande JP, Sheedy PF II, and Romero JC. Noninvasive evaluation of a novel swine model of renal artery stenosis. J Am Soc Nephrol 10: 1455-1465, 1999.
22. Lerman LO, Siripornpitak S, Maffei NL, Sheedy PF II, and Ritman EL. Measurement of in vivo myocardial microcirculatory function with electron beam CT. J Comput Assist Tomogr 23: 390-398, 1999.
23. Li QF and Dai AG. Hypoxia-inducible factor-1 alpha regulates the role of vascular endothelial growth factor on pulmonary arteries of rats with hypoxia-induced pulmonary hypertension. Chin Med J (Engl) 117: 1023-1028, 2004.
24. Matsumoto T, and Claesson-Welsh L. VEGF receptor signal transduction. Sci STKE 112: RE21, 2001.
25. Mehler PS, Coll JR, Estacio R, Esler A, Schrier RW, and Hiatt WR. Intensive blood pressure control reduces the risk of cardiovascular events in patients with peripheral arterial disease and type 2 diabetes. Circulation 107: 753-756, 2003.
26. Michiels C, De Leener F, Arnould T, Dieu M, and Remacle J. Hypoxia stimulates human endothelial cells to release smooth muscle cell mitogens: role of prostaglandins and bFGF. Exp Cell Res 213: 43-54, 1994.
27. Möhlenkamp S, Lerman LO, Lerman A, Behrenbeck TR, Katusic Z, Sheedy PF II, and Ritman EL. Minimally invasive evaluation of coronary microvascular function by electron beam computed tomography. Circulation 102: 2411-2416, 2000.
28. Panting JR, Gatehouse PD, Yang GZ, Grothues F, Firmin DN, Collins P, and Pennell DJ. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med 346: 1948-1953, 2002.
29. Peifley KA and Winkles JA. Angiotensin II and endothelin-1 increase fibroblast growth factor-2 mRNA expression in vascular smooth muscle cells. Biochem Biophys Res Commun 242: 202-208, 1998.
30. Rakusan K, Flanagan MF, Geva T, Southern J, and Van Praagh R. Morphometry of human coronary capillaries during normal growth and the effect of age in left ventricular pressure-overload hypertrophy. Circulation 86: 38-46, 1992.
31. Rodriguez-Porcel M, Herrman J, Chade AR, Krier JD, Breen JF, Lerman A, and Lerman LO. Long-term antioxidant intervention improves myocardial microvascular function in experimental hypertension. Hypertension 43: 493-498, 2004.
32. Rodriguez-Porcel M, Lerman A, Best PJ, Krier JD, Napoli C, and Lerman LO. Hypercholesterolemia impairs myocardial perfusion and permeability: role of oxidative stress and endogenous scavenging activity. J Am Coll Cardiol 37: 806-815, 2001.
33. Rodriguez-Porcel M, Lerman A, Herrmann J, Schwartz RS, Sawamura T, Condorelli M, Napoli C, and Lerman LO. Hypertension exacerbates the effect of hypercholesterolemia on the myocardial microvasculature. Cardiovasc Res 58: 213-221, 2003.
34. Rodriguez-Porcel M, Lerman A, Ritman EL, Wilson SW, Best PJM, and Lerman LO. Altered microvascular structure in experimental hypercholesterolemia. Circulation 102: 2028-2030, 2000.
35. Rodriguez-Porcel M, Lerman LO, Herrmann J, Sawamura T, Napoli C, and Lerman A. Hypercholesterolemia and hypertension have synergistic deleterious effects on coronary endothelial function. Arterioscler Thromb Vasc Biol 23: 885-891, 2003.
36. Shibuya M. Structure and function of VEGF/VEGF-receptor system involved in angiogenesis. Cell Struct Funct 26: 25-35, 2001.
37. Shiojima I, Sato K, Izumiya Y, Schiekofer S, Ito M, Liao R, Colucci WS, and Walsh K. Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest 115: 2108-2118, 2005.
38. Sim EK, Zhang L, Shim WS, Lim YL, and Ge R. Therapeutic angiogenesis for coronary artery disease. J Card Surg 17: 350-354, 2002.
39. Sorop O, Spaan JA, Sweeney TE, and VanBavel E. Effect of steady versus oscillating flow in porcine coronary arterioles. Involvement of NO and superoxide anion. Circ Res 22: 1344-1351, 2003.
40. Stier CT Jr, Chander PN, Rosenfeld L, and Powers CA. Estrogen promotes microvascular pathology in female stroke-prone spontaneously hypertensive rats. Am J Physiol Endocrinol Metab 285: E232-E239, 2003.
41. Tomanek RJ, Palmer PJ, Peiffer GL, Schreiber KL, Eastham CL, and Marcus ML. Morphometry of canine coronary arteries, arterioles, and capillaries during hypertension and left ventricular hypertrophy. Circ Res 58: 38-46, 1986.
42. Treasure CB, Klein JL, Vita JA, Manoukian SV, Renwick GH, Selwyn AP, Ganz P, and Alexander RW. Hypertension and left ventricular hypertrophy are associated with impaired endothelium-mediated relaxation in human coronary resistance vessels. Circulation 87: 86-93, 1993.
43. Wang L, Xiong M, Che D, Liu S, Hao C, and Zheng X. The effect of hypoxia on expression of basic fibroblast growth factor in pulmonary vascular pericytes. J Tongji Med Univ 20: 265-267, 2000.
44. Yamani MH and Massie BM. Hypertension, myocardial ischemia, and sudden death. Curr Opin Cardiol 9: 542-550, 1994.
45. Yurenev AP, DeQuattro V, Dubov PB, Ostroumov EN, Nikulin IA, Konyaeva EB, Balyakina EV, Atachanov SE, Kosenko AI, Popov EG, Gabbasov ZA, and Gulyaev VP. Silent myocardial ischemia in patients with essential hypertension. Am J Hypertens 5: 169S-174S, 1992.
46. 2) and active renin in hypertension of adrenal origin. J Endocrinol Invest 27: 742-746, 2004.
47. Zhu XY, Chade AR, Rodriguez-Porcel M, Bentley MD, Ritman EL, Lerman A, and Lerman LO. Cortical microvascular remodeling in the stenotic kidney: role of increased oxidative stress. Arterioscler Thromb Vasc Biol 24: 1854-1859, 2004.
48. Zhu XY, Rodriguez-Porcel M, Bentley MD, Chade AR, Sica V, Napoli C, Caplice N, Ritman EL, Lerman A, and Lerman LO. Antioxidant intervention attenuates myocardial neovascularization in hypercholesterolemia. Circulation 109: 2109-2115, 2004.